FDA fast tracks treatment for immune checkpoint inhibitor–resistant urothelial carcinoma
March 13th 2023“There is an urgent need for new treatment options for [patients with] urothelial carcinoma, many of whom find themselves out of options after progressing on immune checkpoint inhibitors," said Sergio Santillana, MD.